Article

Validation of a Severe Acute Respiratory Syndrome Coronavirus 2 Microneutralization Assay for Evaluation of Vaccine Immunogenicity

2023-12-04

Abstract excerpt

As variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue to emerge, assessment of vaccine immunogenicity remains a critical factor to support continued vaccination. To this end, an in vitro microneutralization (MN50) assay was validated to quantitate SARS-CoV-2 neutralizing antibodies against ancestral and variant strains (Beta, Delta, Omicron BA.1, Omicron BA.5 and XBB.1.5) in human se...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f8581517-9dac-53a0-98aa-e6c609bf8e7e
DOI: 10.20944/preprints202312.0120.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Validation of a Severe Acute Respiratory Syndrome Coronavirus 2 Microneutralization Assay for Evaluation of Vaccine ImmunogenicityDOI 10.20944/preprints202312.0120.v1Read

IMMUNO-COV™ v2.0: Development and Validation of a High-Throughput Clinical Assay for Measuring SARS-CoV-2-Neutralizing Antibody TitersSemantic proximity Read

Standardization and Harmonization of SARS-COV-2 Assays Offered by the CEPI Centralized Laboratory Network in Support for Vaccine Clinical TrialsSemantic proximity Read

Establishment of human post-vaccination SARS-CoV-2 standard reference seraSemantic proximity Read

Third dose of COVID-19 vaccine, CVnCoV, increased neutralizing activity against SARS-CoV-2 wild-type and Delta variantSemantic proximity Read

Accurate evaluation of live-virus microneutralization for SARS-CoV-2 variant JN.1Semantic proximity Read

Rapid, High Throughput, Automated Detection Of SARS-Cov-2 Neutralizing Antibodies Against Native-Like Vaccine And Delta Variant Spike TrimersSemantic proximity Read

Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against native-like vaccine and delta variant spike trimersSemantic proximity Read

Development and validation of IMMUNO-COV™: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2Semantic proximity Read

Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 VariantsSemantic proximity Read

Biologically contained Ebola virus enables standardised neutralisation testing for preclinical and clinical immunogenicity assessmentSemantic proximity Read

OraSure InteliSwab™ Rapid Antigen Test Performance with the SARS-CoV-2 Variants of Concern—Alpha, Beta, Gamma, Delta, and OmicronSemantic proximity Read

Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera.Semantic proximity Read